NorthView Acquisition Corp. Faces Delisting Concerns
Ticker: NVACW · Form: 8-K · Filed: Dec 26, 2024 · CIK: 1859807
| Field | Detail |
|---|---|
| Company | Northview Acquisition CORP (NVACW) |
| Form Type | 8-K |
| Filed Date | Dec 26, 2024 |
| Risk Level | high |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001, $11.50 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-rule-violation, 8-k
Related Tickers: NVAC
TL;DR
NVAC might get delisted - big trouble for shareholders.
AI Summary
NorthView Acquisition Corp. (NVAC) filed an 8-K on December 20, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The filing indicates that the company may be facing issues related to its listing status on the stock exchange.
Why It Matters
This filing suggests potential financial distress or non-compliance with exchange rules for NorthView Acquisition Corp., which could significantly impact its stock value and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's ability to trade on a major exchange, posing a significant risk to its operations and shareholder value.
Key Players & Entities
- NorthView Acquisition Corp. (company) — Registrant
- December 20, 2024 (date) — Date of earliest event reported
- 001-41177 (other) — SEC File Number
FAQ
What specific rule or standard has NorthView Acquisition Corp. failed to satisfy, leading to the notice of delisting?
The filing does not specify the exact rule or standard that NorthView Acquisition Corp. has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is December 20, 2024.
What is the SEC file number for NorthView Acquisition Corp.?
The SEC file number for NorthView Acquisition Corp. is 001-41177.
What type of company is NorthView Acquisition Corp. based on its SIC code?
NorthView Acquisition Corp. is classified under SIC code 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Where is NorthView Acquisition Corp. incorporated?
NorthView Acquisition Corp. is incorporated in Delaware.
Filing Stats: 1,065 words · 4 min read · ~4 pages · Grade level 12.4 · Accepted 2024-12-26 16:30:40
Key Financial Figures
- $0.0001 — red Shares of common stock, par value $0.0001 per share NVAC The NASDAQ Stock Mar
- $11.50 — of common stock at an exercise price of $11.50 per whole share NVACW The NASDAQ St
Filing Documents
- ea0225761-8k_north.htm (8-K) — 42KB
- ea022576101ex99-1_north.htm (EX-99.1) — 6KB
- 0001213900-24-112686.txt ( ) — 275KB
- nvac-20241220.xsd (EX-101.SCH) — 4KB
- nvac-20241220_def.xml (EX-101.DEF) — 27KB
- nvac-20241220_lab.xml (EX-101.LAB) — 37KB
- nvac-20241220_pre.xml (EX-101.PRE) — 25KB
- ea0225761-8k_north_htm.xml (XML) — 7KB
01. Notice of Delisting or Failure to Satisfy a Continued
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On December 20, 2024, NorthView Acquisition Corp. (the "Company") received a written notice (the "Notice") from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") that the Company's securities will be delisted from The Nasdaq Stock Market by reason of the failure of the Company to complete its initial business combination by December 20, 2024 (36 months from the effectiveness of its IPO registration statement) as required by Listing Rule IM-5101-2. Accordingly, trading in the Company's Common Stock, Rights and Warrants will be suspended at the opening of business on December 27, 2024 and a Form 25-NSE will be filed by Nasdaq with the Securities and Exchange Commission, which will remove the Company's securities from on the Nasdaq Stock Market. The Company has applied to quote its Common Stock, Rights and Warrants on the OTCQB Market operated on The OTC Market systems ("OTC Market") under the symbols "NVAC," "NVACR" and "NVACW." In the event that the Company's Common Stock, Rights and Warrants are not admitted to trading on the OTCQB Market, we expect the securities to be quoted on the OTC Markets' Pink Market. There is no guarantee, however, that a broker will continue to make a market in the Company's securities or that quotation thereof will continue on the OTC Market or otherwise. Notwithstanding the delisting of the Company's securities from Nasdaq, it remains the intention of the Company to continue to pursue the previously announced initial business combination with Profusa, Inc. as well as the listing of its Common Stock and Warrants on The Nasdaq Stock Market in connection therewith. However, there can be no assurance that the initial business combination will ultimately be successful or the Company's securities will ultimately be listed on Nasdaq. The Company will remain a reporting entity under the Securities E
01. Other Events
Item 8.01. Other Events. On December 26, 2024, the Company issued a press release regarding the Notice. The press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Forward-Looking Statements
Forward-Looking Statements This Form 8-K contains forward-looking statements, including statements about the financial condition, results of operations, earnings outlook and prospects of the Company. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. Forward-looking statements are typically identified by words such as "plan," "believe," "expect," "anticipate," "intend," "outlook," "estimate," "forecast," "project," "continue," "could," "may," "might," "possible," "potential," "predict," "should," "would" and other similar words and expressions, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements are based on the current expectations of the Company's management and are inherently subject to uncertainties and changes in circumstances and their potential effects and speak only as of the date of such statement. There can be no assurance that future developments will be those that have been anticipated. These forward-looking statements involve a number of risks, uncertainties or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. For additional information about factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to our filings with the SEC. Forward-looking statements represent management's current expectations and are inherently uncertain. Except to the extent required by applicable law, we do not undertake any obligation to update or revise forward-looking statements made by us to reflect subsequent events or circumstances.
01. Financial
Item 9.01. Financial (c) Exhibits: Exhibit No. Description 99.1 Press Release dated December 26, 2024 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) 1 SIGNATURE Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NORTHVIEW ACQUISITION CORP. Dated: December 26, 2024 By: /s/ Fred Knechtel Name: Fred Knechtel Title: Chief Financial Officer 2